Variational AI Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase clinical probability of success. Variational AI works with leading biopharmaceutical partners and is developing its own internal pipeline.

Company Highlights
Year Founded

2019

icon-altEmployees

15

Location (HQ)

CAN

Since Last Funding

2 years 11 months

Monthly Website Visitors

837

icon-altTotal Investment Amt

$3.7M

Last Funding Round

Seed

icon-altMoM Headcount Growth

-6.21%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Machine Learning

Biotechnology

Biotechnology Research

Pharmaceutical Manufacturing

Generative AI

Pharmaceuticals